Development of a novel bi-specific monoclonal antibody approach for tumour targeting

por Koumarianou, A A, Hudson, M, Williams, R, Epenetos, A A, Stamp, G W H
Publicado 1999

A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer

por Carlsson, G., Koumarianou, A., Guren, T.K., Haux, J., Katsaounis, P., Kentepozidis, N., Pfeiffer, P., Brændengen, M., Mavroudis, D., Taflin, H., Skintemo, L., Tell, R., Papadimitriou, C.
Publicado 2022

P1230: PET/CT IMAGING FOR RESPONSE ASSESSMENT AND TREATMENT GUIDANCE AFTER RITUXIMAB-DOSE-ADJUSTED-EPOCH(R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL):THE GREEK...

por Vassilakopoulos, T., Piperidou, A., Mellios, Z., Verigou, E., Kalpadakis, C., Katodritou, E., Papageorgiou, S., Chatzidimitriou, C., Giatra, C., Leonidopoulou, T., Xanthopoulos, V., Karakatsanis, S., Gainaru, G., Vrakidou, E., Koumarianou, A., Hatzimichael, E., Verrou, E., Tsirogianni, M., Drandakis, I., Lefaki, M. A., Liaskas, A., Kopsaftopoulou, A., Lampropoulou, P., Kanellias, N., Zikos, P., Liapi, D., Karianakis, G., Grentzelias, D., Papadaki, E., Siakantaris, M., Tsirigotis, P., Panitsas, F., Plata, E., Bakiri, M., Datseris, I., Chatziioannou, S., Prassopoulos, V., Skoura, E., Angelopoulou, M., Symeonidis, A., Karmiris, T., Rontogianni, P.
Publicado 2022

P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

por Vassilakopoulos, T., Ferhanoglu, B., Horowitz, N. A., Apostolidis, J., Mellios, Z., Kaynar, L., Zektser, M., Symeonidis, A., Piperidou, A., Kalpadaki, C., Akay, O. M., Atalar, S. C., Sayyed, A., Katodritou, E., Leonidopoulou, T., Papageorgiou, S., Tadmor, T., Gutwein, O., Karakatsanis, S., Ganzel, C., Karianakis, G., Isenberg, G., Gainaru, G., Vrakidou, E., Palassopoulou, M., Ozgur, M., Siakantaris, M., Paydas, S., Tsirigotis, P., Tsirogianni, M., Hatzimichael, E., Tuglular, T. F., Chatzidimitriou, C., Liaskas, A., Lefaki, M. A., Kanellias, N., Zikos, P., Koumarianou, A., Gafter-Gvili, A., Angelopoulou, M., Karmiris, T., Gurion, R.
Publicado 2022

P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

por Vassilakopoulos, Theodoros, Ferhanoglu, B, Horowitz, Na, Apostolidis, J, Mellios, Z, Piperidou, Alexia, Kaynar, L, Zektser, M, Giotasmater, A, Hospital, Dei, Malta, Msida, Symeonidis, A, Kalpadakis, C, Agathocleous, A, Akay, Om, Sayyed, A, Atalar, Sc, Katodritou, E, Leonidopoulou, T, Papageorgiou, Sg, Tadmor, T., Gutwein, O, Karakatsanis, S, Ganzel, C, Karianakis, G., Isenberg, G. Y., Gainaru, G, Vrakidou, E., Palassopoulou, M, Ozgur, M, Siakantaris, Marina, Paydas, S, Tsirigotis, P, Tsirogianni, M, Hatzimichael, E, Tugular, Tf, Assimakopoulos, Jv, Ligdi, L, Liaskas, A, Aikaterini Lefaki, Maria, Labropoulou, P, Kopsaftopoulou, A, Verrou, E, Kanellias, M, Zikos, P, Koumarianou, A, Gafter-Gvili, A, Bouzani, M, Angelopoulou, Mk, Karmiris, T, Gurion, R
Publicado 2023